1333331-74-0 Usage
Chemical class
Dihydropyridine derivative
Structural components
1,4-dihydropyridine core
Benzyloxy group
Biphenyl moiety
Functional group
Carboxylic acid group
Potential pharmaceutical applications
Structural similarity to calcium channel blockers
Treatment of hypertension and angina
Interaction with biological systems
Potential as a ligand for specific receptors or enzymes
Presence of carboxylic acid group
Further research
Investigation into pharmacological properties
Development of new therapeutic agents
1-([1,1'-Biphenyl]-3-yl)-5-(benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylic acid is a dihydropyridine derivative with a carboxylic acid group, formed by the fusion of a 1,4-dihydropyridine core with a benzyloxy group and a biphenyl moiety. It has potential pharmaceutical applications due to its structural similarity to calcium channel blockers, which are used in the treatment of hypertension and angina. The presence of the carboxylic acid group also suggests potential for interaction with biological systems, potentially as a ligand for specific receptors or enzymes. Further research and investigation into the pharmacological properties of 1-([1,1'-Biphenyl]-3-yl)-5-(benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylic acid could lead to the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1333331-74-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,3,3,3 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1333331-74:
(9*1)+(8*3)+(7*3)+(6*3)+(5*3)+(4*3)+(3*1)+(2*7)+(1*4)=120
120 % 10 = 0
So 1333331-74-0 is a valid CAS Registry Number.
1333331-74-0Relevant academic research and scientific papers
INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS
-
, (2011/10/03)
The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved
